Plunkett Research Online: BioNTech SE

BIONTECH SE (BNTX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to .....



BioNTech SE
Ticker: BNTX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 49 6131 9084 0
Fax: 49 6131 9084 2121
Address: An der Goldgrube 12
Mainz, RP D-55131 Germany

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biopharmaceuticals
Immunotherapies
Novel Cancer Therapies
Infectious Disease Therapies
Research and Development
Manufacturing
mRNA and Programmable Cell Therapies
Antibody Therapies
Contacts Description
Ugur SahinCEO/Co-Founder
Jens HolsteinCFO
See More
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to .....See More See More

Auditor: EY GmbH Wirtschaftsprufungsgesellschaft
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (EUR)Bonus (EUR)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: